Literature DB >> 11122019

Analysis of dendritic cell populations using a revised histological staging of morphoea.

T K Gilmour1, B Wilkinson, S N Breit, S Kossard.   

Abstract

BACKGROUND: Recent studies have suggested that dermal dendritic cells (DDCs) may play a part in maintaining the structure of the dermis and in dermal immune modulation. Alteration in the population of DDCs has been noted in localized and systemic scleroderma, particularly a decline in the number of CD34+ DDCs. Objectives To define the alteration of the DDC populations with respect to the histological stage of morphoea.
METHODS: We examined 33 biopsies of morphoea, categorized into four histological stages, and examined the DDC population (CD34+ DDCs and factor XIIIa+ DDCs), the lymphocytic infiltrate, and tenascin (extracellular matrix glycoprotein) and transforming growth factor (TGF)-beta1 expression in each biopsy.
RESULTS: As the dermis became less inflammatory and more sclerotic, there was a significant decline in the number of CD34+ DDCs and an increase in the number of factor XIIIa+ DDCs. The pan-T-cell infiltrate (UCHL-1/CD45RO) and tenascin deposition exhibited a similar pattern, with elevated expression in inflammatory stages and a decrease in expression as the dermis became sclerotic. TGF-beta1 was significantly elevated in three of the four histological stages of morphoea, in both the inflammatory and sclerotic stages. The proposed four-stage histological analysis of morphoea biopsies was a useful basis for studying dendritic cells and mediators in cutaneous sclerosis.
CONCLUSIONS: Our study indicates that there is a reciprocal relationship between CD34+ DDCs and factor XIIIa+ DDCs in morphoea that correlates with the relative degrees of inflammation and sclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122019     DOI: 10.1046/j.1365-2133.2000.03886.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

Review 1.  Dendritic cells: novel players in fibrosis and scleroderma.

Authors:  Theresa T Lu
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 2.  Scleroderma-like cutaneous syndromes.

Authors:  Yasuji Mori; Veli-Matti Kahari; John Varga
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

3.  Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.

Authors:  Banafsheh Nazari; Lisa M Rice; Giuseppina Stifano; Alexander M S Barron; Yu Mei Wang; Tess Korndorf; Jungeun Lee; Jag Bhawan; Robert Lafyatis; Jeffrey L Browning
Journal:  Am J Pathol       Date:  2016-08-23       Impact factor: 4.307

4.  12E2: a cloned murine dermal cell with features of dermal dendrocytes and capacity to produce pathologic changes resembling early Kaposi's sarcoma.

Authors:  Masatoshi Deguchi; Diana Whitaker-Menezes; Stephen C Jones; Setsuya Aiba; Satoshi Nakagawa; Hachiro Tagami; Robert Korngold; George F Murphy
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 5.  The role of dendritic cells and regulatory T cells in the pathogenesis of morphea.

Authors:  Agnieszka Osmola-Mańkowska; Ewa Teresiak-Mikołajczak; Aleksandra Dańczak-Pazdrowska; Michał Kowalczyk; Ryszard Żaba; Zygmunt Adamski
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

6.  Expression of selected genes of dendritic and Treg cells in blood and skin of morphea patients treated with UVA1 phototherapy.

Authors:  Agnieszka J Osmola-Mańkowska; Ewa Teresiak-Mikołajczak; Michał J Kowalczyk; Ryszard W Żaba; Zygmunt Adamski; Aleksandra Dańczak-Pazdrowska
Journal:  Arch Med Sci       Date:  2018-02-21       Impact factor: 3.318

Review 7.  Morphea: progress to date and the road ahead.

Authors:  Laila Abbas; Adrienne Joseph; Elaine Kunzler; Heidi T Jacobe
Journal:  Ann Transl Med       Date:  2021-03

8.  Autoantigen microarrays reveal myelin basic protein autoantibodies in morphea.

Authors:  Jane L Zhu; Ricardo T Paniagua; Henry W Chen; Stephanie Florez-Pollack; Elaine Kunzler; Noelle Teske; Yevgeniya Byekova Rainwater; Quan-Zhen Li; Gregory A Hosler; Wenhao Li; Denise M O Ramirez; Nancy L Monson; Heidi T Jacobe
Journal:  J Transl Med       Date:  2022-01-24       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.